R. Don Elsey
2020 - Lyra Therapeutics
In 2020, R. Don Elsey earned a total compensation of $760.7K as Chief Financial Officer at Lyra Therapeutics, a 3% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $150,000 |
|---|---|
| Option Awards | $224,350 |
| Salary | $362,558 |
| Other | $23,778 |
| Total | $760,686 |
Elsey received $362.6K in salary, accounting for 48% of the total pay in 2020.
Elsey also received $150K in non-equity incentive plan, $224.4K in option awards and $23.8K in other compensation.
Rankings
In 2020, R. Don Elsey's compensation ranked 9,679th out of 13,090 executives tracked by ExecPay. In other words, Elsey earned more than 26.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,679 out of 13,090 | 26th |
Division Manufacturing | 4,165 out of 5,621 | 26th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 536 out of 799 | 33rd |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 332 out of 495 | 33rd |
Industry Surgical and Medical Instruments and Apparatus | 217 out of 313 | 31st |
Source: SEC filing on April 14, 2021.
Elsey's colleagues
We found two more compensation records of executives who worked with R. Don Elsey at Lyra Therapeutics in 2020.